Lagociclovir valactate

Drug Profile

Lagociclovir valactate

Alternative Names: 204937; DWP 10019; MIV-210

Latest Information Update: 09 Sep 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medivir AB
  • Developer Daewoong Pharmaceutical; Medivir AB
  • Class Antivirals; Lactates; Purine nucleosides; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hepatitis B; HIV infections

Most Recent Events

  • 06 Sep 2013 Discontinued - Phase-I for Hepatitis B in South Korea (PO)
  • 06 Sep 2013 Discontinued - Phase-I for Hepatitis B in United Kingdom (PO)
  • 31 Dec 2012 Phase I development is ongoing in United Kingdom
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top